nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B17—prostate cancer	0.313	0.768	CbGaD
Losartan—CYP3A5—prostate cancer	0.0313	0.0766	CbGaD
Losartan—ACE—prostate cancer	0.0288	0.0706	CbGaD
Losartan—SLCO1B3—Cabazitaxel—prostate cancer	0.0239	0.0659	CbGbCtD
Losartan—CYP2C19—prostate cancer	0.0213	0.0521	CbGaD
Losartan—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0153	0.0421	CbGbCtD
Losartan—SLCO1B1—Cabazitaxel—prostate cancer	0.0139	0.0384	CbGbCtD
Losartan—SLCO1B1—Estrone—prostate cancer	0.0136	0.0375	CbGbCtD
Losartan—CYP3A4—prostate cancer	0.0135	0.0332	CbGaD
Losartan—SLCO1B3—Estradiol—prostate cancer	0.0134	0.037	CbGbCtD
Losartan—UGT1A1—Estradiol—prostate cancer	0.0113	0.0311	CbGbCtD
Losartan—UGT2B7—Epirubicin—prostate cancer	0.0109	0.0302	CbGbCtD
Losartan—ALB—Abiraterone—prostate cancer	0.0103	0.0284	CbGbCtD
Losartan—CYP2C8—Nilutamide—prostate cancer	0.0096	0.0265	CbGbCtD
Losartan—SLCO1B1—Conjugated Estrogens—prostate cancer	0.00889	0.0245	CbGbCtD
Losartan—CYP3A5—Flutamide—prostate cancer	0.00828	0.0228	CbGbCtD
Losartan—CYP2C19—Bicalutamide—prostate cancer	0.00806	0.0222	CbGbCtD
Losartan—CYP2C19—Nilutamide—prostate cancer	0.00806	0.0222	CbGbCtD
Losartan—SLCO1B3—Docetaxel—prostate cancer	0.00801	0.0221	CbGbCtD
Losartan—CYP2C8—Abiraterone—prostate cancer	0.00796	0.022	CbGbCtD
Losartan—SLCO1B1—Estradiol—prostate cancer	0.00781	0.0215	CbGbCtD
Losartan—ALB—Estrone—prostate cancer	0.00744	0.0205	CbGbCtD
Losartan—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00741	0.0205	CbGbCtD
Losartan—UGT1A1—Etoposide—prostate cancer	0.00736	0.0203	CbGbCtD
Losartan—CYP2C9—Nilutamide—prostate cancer	0.0067	0.0185	CbGbCtD
Losartan—CYP2C9—Bicalutamide—prostate cancer	0.0067	0.0185	CbGbCtD
Losartan—CYP2C19—Flutamide—prostate cancer	0.00667	0.0184	CbGbCtD
Losartan—CYP1A2—Flutamide—prostate cancer	0.00616	0.017	CbGbCtD
Losartan—CYP3A5—Cabazitaxel—prostate cancer	0.00612	0.0169	CbGbCtD
Losartan—ABCB1—Estramustine—prostate cancer	0.00604	0.0167	CbGbCtD
Losartan—CYP3A5—Estrone—prostate cancer	0.00598	0.0165	CbGbCtD
Losartan—CYP2C8—Cabazitaxel—prostate cancer	0.00589	0.0162	CbGbCtD
Losartan—SLC22A6—Conjugated Estrogens—prostate cancer	0.00572	0.0158	CbGbCtD
Losartan—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00513	0.0141	CbGbCtD
Losartan—CYP1A2—Estrone—prostate cancer	0.00445	0.0123	CbGbCtD
Losartan—ALB—Estradiol—prostate cancer	0.00428	0.0118	CbGbCtD
Losartan—UGT2B17—prostate gland—prostate cancer	0.00405	0.116	CbGeAlD
Losartan—CYP2C9—Estrone—prostate cancer	0.00401	0.0111	CbGbCtD
Losartan—ABCB1—Cabazitaxel—prostate cancer	0.00398	0.011	CbGbCtD
Losartan—CYP3A4—Bicalutamide—prostate cancer	0.00389	0.0107	CbGbCtD
Losartan—ABCB1—Estrone—prostate cancer	0.00389	0.0107	CbGbCtD
Losartan—ALB—Prednisone—prostate cancer	0.00368	0.0101	CbGbCtD
Losartan—CYP3A4—Estramustine—prostate cancer	0.00362	0.00999	CbGbCtD
Losartan—ABCB1—Ethinyl Estradiol—prostate cancer	0.00347	0.00957	CbGbCtD
Losartan—CYP3A5—Estradiol—prostate cancer	0.00344	0.00948	CbGbCtD
Losartan—CYP2C8—Estradiol—prostate cancer	0.0033	0.00912	CbGbCtD
Losartan—CYP3A4—Abiraterone—prostate cancer	0.00323	0.0089	CbGbCtD
Losartan—CYP3A4—Flutamide—prostate cancer	0.00323	0.0089	CbGbCtD
Losartan—CYP2C9—Capecitabine—prostate cancer	0.00304	0.00839	CbGbCtD
Losartan—UGT2B17—epithelium—prostate cancer	0.00298	0.0852	CbGeAlD
Losartan—CYP1A2—Conjugated Estrogens—prostate cancer	0.00291	0.00804	CbGbCtD
Losartan—CYP2C19—Estradiol—prostate cancer	0.00277	0.00765	CbGbCtD
Losartan—CYP1A2—Estradiol—prostate cancer	0.00256	0.00706	CbGbCtD
Losartan—ABCB1—Conjugated Estrogens—prostate cancer	0.00255	0.00703	CbGbCtD
Losartan—CYP3A4—Cabazitaxel—prostate cancer	0.00239	0.00659	CbGbCtD
Losartan—CYP2C19—Prednisone—prostate cancer	0.00238	0.00658	CbGbCtD
Losartan—CYP3A4—Estrone—prostate cancer	0.00233	0.00644	CbGbCtD
Losartan—ABCB1—Mitoxantrone—prostate cancer	0.00232	0.00639	CbGbCtD
Losartan—CYP2C9—Estradiol—prostate cancer	0.0023	0.00636	CbGbCtD
Losartan—CYP3A5—Etoposide—prostate cancer	0.00224	0.00619	CbGbCtD
Losartan—ABCB1—Estradiol—prostate cancer	0.00224	0.00617	CbGbCtD
Losartan—UGT1A1—urine—prostate cancer	0.00219	0.0628	CbGeAlD
Losartan—CYP2C8—Etoposide—prostate cancer	0.00216	0.00595	CbGbCtD
Losartan—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00208	0.00574	CbGbCtD
Losartan—CYP3A5—Docetaxel—prostate cancer	0.00205	0.00566	CbGbCtD
Losartan—ABCB1—Prednisone—prostate cancer	0.00192	0.00531	CbGbCtD
Losartan—SLC2A9—prostate gland—prostate cancer	0.00179	0.0513	CbGeAlD
Losartan—SLC22A12—renal system—prostate cancer	0.00178	0.0509	CbGeAlD
Losartan—CYP1A2—Etoposide—prostate cancer	0.00167	0.00461	CbGbCtD
Losartan—UGT1A10—renal system—prostate cancer	0.00156	0.0446	CbGeAlD
Losartan—CYP3A4—Conjugated Estrogens—prostate cancer	0.00153	0.00421	CbGbCtD
Losartan—SLC2A9—seminal vesicle—prostate cancer	0.00152	0.0434	CbGeAlD
Losartan—ABCB1—Etoposide—prostate cancer	0.00146	0.00403	CbGbCtD
Losartan—ACE—urine—prostate cancer	0.00141	0.0405	CbGeAlD
Losartan—CYP3A4—Mitoxantrone—prostate cancer	0.00139	0.00383	CbGbCtD
Losartan—CYP3A4—Estradiol—prostate cancer	0.00134	0.0037	CbGbCtD
Losartan—ABCB1—Docetaxel—prostate cancer	0.00134	0.00369	CbGbCtD
Losartan—SLC2A9—renal system—prostate cancer	0.00122	0.035	CbGeAlD
Losartan—CYP2C19—urine—prostate cancer	0.00119	0.034	CbGeAlD
Losartan—CYP3A4—Prednisone—prostate cancer	0.00115	0.00318	CbGbCtD
Losartan—ABCB1—Doxorubicin—prostate cancer	0.000996	0.00275	CbGbCtD
Losartan—CYP1A2—urine—prostate cancer	0.000971	0.0278	CbGeAlD
Losartan—UGT2B7—prostate gland—prostate cancer	0.000926	0.0265	CbGeAlD
Losartan—CYP2C9—urine—prostate cancer	0.000922	0.0264	CbGeAlD
Losartan—CYP3A4—Etoposide—prostate cancer	0.000875	0.00241	CbGbCtD
Losartan—CYP3A4—Docetaxel—prostate cancer	0.0008	0.00221	CbGbCtD
Losartan—SLC2A9—testis—prostate cancer	0.00079	0.0226	CbGeAlD
Losartan—UGT1A1—prostate gland—prostate cancer	0.000787	0.0225	CbGeAlD
Losartan—CYP3A4—urine—prostate cancer	0.000703	0.0201	CbGeAlD
Losartan—AGTR1—prostate gland—prostate cancer	0.000687	0.0197	CbGeAlD
Losartan—UGT2B7—renal system—prostate cancer	0.000631	0.0181	CbGeAlD
Losartan—CYP3A4—Doxorubicin—prostate cancer	0.000597	0.00165	CbGbCtD
Losartan—SLC2A9—lymph node—prostate cancer	0.000572	0.0164	CbGeAlD
Losartan—UGT1A1—renal system—prostate cancer	0.000537	0.0154	CbGeAlD
Losartan—ACE—prostate gland—prostate cancer	0.000507	0.0145	CbGeAlD
Losartan—AGTR1—epithelium—prostate cancer	0.000505	0.0145	CbGeAlD
Losartan—AGTR1—renal system—prostate cancer	0.000468	0.0134	CbGeAlD
Losartan—SLCO1B1—renal system—prostate cancer	0.000446	0.0128	CbGeAlD
Losartan—ACE—seminal vesicle—prostate cancer	0.000429	0.0123	CbGeAlD
Losartan—UGT2B7—testis—prostate cancer	0.000408	0.0117	CbGeAlD
Losartan—ACE—epithelium—prostate cancer	0.000373	0.0107	CbGeAlD
Losartan—ACE—renal system—prostate cancer	0.000346	0.0099	CbGeAlD
Losartan—ACE—urethra—prostate cancer	0.00034	0.00972	CbGeAlD
Losartan—CYP3A5—prostate gland—prostate cancer	0.000336	0.00962	CbGeAlD
Losartan—AGTR1—testis—prostate cancer	0.000303	0.00866	CbGeAlD
Losartan—ACE—bone marrow—prostate cancer	0.000261	0.00748	CbGeAlD
Losartan—CYP2C8—renal system—prostate cancer	0.000254	0.00727	CbGeAlD
Losartan—CYP1A2—renal system—prostate cancer	0.000238	0.0068	CbGeAlD
Losartan—ALB—testis—prostate cancer	0.000233	0.00668	CbGeAlD
Losartan—CYP3A5—renal system—prostate cancer	0.000229	0.00656	CbGeAlD
Losartan—ACE—testis—prostate cancer	0.000223	0.0064	CbGeAlD
Losartan—AGTR1—lymph node—prostate cancer	0.000219	0.00628	CbGeAlD
Losartan—ABCB1—prostate gland—prostate cancer	0.000179	0.00511	CbGeAlD
Losartan—CYP3A4—renal system—prostate cancer	0.000172	0.00492	CbGeAlD
Losartan—ALB—lymph node—prostate cancer	0.000169	0.00485	CbGeAlD
Losartan—CYP2C8—testis—prostate cancer	0.000164	0.0047	CbGeAlD
Losartan—ACE—lymph node—prostate cancer	0.000162	0.00464	CbGeAlD
Losartan—ABCB1—seminal vesicle—prostate cancer	0.000151	0.00432	CbGeAlD
Losartan—ABCB1—epithelium—prostate cancer	0.000131	0.00376	CbGeAlD
Losartan—Telmisartan—CYP2C19—prostate cancer	0.000124	0.436	CrCbGaD
Losartan—ABCB1—renal system—prostate cancer	0.000122	0.00348	CbGeAlD
Losartan—ABCB1—urethra—prostate cancer	0.00012	0.00342	CbGeAlD
Losartan—Tasosartan—CYP3A4—prostate cancer	9.68e-05	0.34	CrCbGaD
Losartan—ABCB1—bone marrow—prostate cancer	9.2e-05	0.00263	CbGeAlD
Losartan—ABCB1—testis—prostate cancer	7.87e-05	0.00225	CbGeAlD
Losartan—Irbesartan—CYP3A4—prostate cancer	6.36e-05	0.224	CrCbGaD
Losartan—ABCB1—lymph node—prostate cancer	5.7e-05	0.00163	CbGeAlD
Losartan—Vertigo—Prednisone—prostate cancer	2.58e-05	0.000253	CcSEcCtD
Losartan—Hepatitis—Epirubicin—prostate cancer	2.58e-05	0.000253	CcSEcCtD
Losartan—Thrombocytopenia—Capecitabine—prostate cancer	2.58e-05	0.000253	CcSEcCtD
Losartan—Syncope—Prednisone—prostate cancer	2.58e-05	0.000253	CcSEcCtD
Losartan—Tachycardia—Capecitabine—prostate cancer	2.57e-05	0.000252	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—prostate cancer	2.57e-05	0.000252	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—prostate cancer	2.56e-05	0.000251	CcSEcCtD
Losartan—Sweating—Doxorubicin—prostate cancer	2.55e-05	0.00025	CcSEcCtD
Losartan—Hyperhidrosis—Capecitabine—prostate cancer	2.54e-05	0.00025	CcSEcCtD
Losartan—Hypotension—Docetaxel—prostate cancer	2.54e-05	0.000249	CcSEcCtD
Losartan—Loss of consciousness—Prednisone—prostate cancer	2.52e-05	0.000248	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—prostate cancer	2.51e-05	0.000246	CcSEcCtD
Losartan—Anorexia—Capecitabine—prostate cancer	2.51e-05	0.000246	CcSEcCtD
Losartan—Nausea—Estradiol—prostate cancer	2.51e-05	0.000246	CcSEcCtD
Losartan—Vomiting—Mitoxantrone—prostate cancer	2.5e-05	0.000245	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—prostate cancer	2.49e-05	0.000245	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—prostate cancer	2.48e-05	0.000244	CcSEcCtD
Losartan—Rash—Mitoxantrone—prostate cancer	2.48e-05	0.000243	CcSEcCtD
Losartan—Dermatitis—Mitoxantrone—prostate cancer	2.48e-05	0.000243	CcSEcCtD
Losartan—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.48e-05	0.000243	CcSEcCtD
Losartan—Headache—Mitoxantrone—prostate cancer	2.46e-05	0.000242	CcSEcCtD
Losartan—Hypotension—Capecitabine—prostate cancer	2.46e-05	0.000241	CcSEcCtD
Losartan—Insomnia—Docetaxel—prostate cancer	2.46e-05	0.000241	CcSEcCtD
Losartan—Arthralgia—Prednisone—prostate cancer	2.44e-05	0.00024	CcSEcCtD
Losartan—Myalgia—Prednisone—prostate cancer	2.44e-05	0.00024	CcSEcCtD
Losartan—Paraesthesia—Docetaxel—prostate cancer	2.44e-05	0.000239	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—prostate cancer	2.44e-05	0.000239	CcSEcCtD
Losartan—Anxiety—Prednisone—prostate cancer	2.44e-05	0.000239	CcSEcCtD
Losartan—Dyspnoea—Docetaxel—prostate cancer	2.42e-05	0.000238	CcSEcCtD
Losartan—Somnolence—Docetaxel—prostate cancer	2.42e-05	0.000237	CcSEcCtD
Losartan—Discomfort—Prednisone—prostate cancer	2.42e-05	0.000237	CcSEcCtD
Losartan—Hypersensitivity—Etoposide—prostate cancer	2.41e-05	0.000236	CcSEcCtD
Losartan—Tinnitus—Epirubicin—prostate cancer	2.41e-05	0.000236	CcSEcCtD
Losartan—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.4e-05	0.000235	CcSEcCtD
Losartan—Flushing—Epirubicin—prostate cancer	2.39e-05	0.000235	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—prostate cancer	2.39e-05	0.000235	CcSEcCtD
Losartan—Dyspepsia—Docetaxel—prostate cancer	2.39e-05	0.000235	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—prostate cancer	2.39e-05	0.000234	CcSEcCtD
Losartan—Insomnia—Capecitabine—prostate cancer	2.38e-05	0.000234	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—prostate cancer	2.38e-05	0.000233	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—prostate cancer	2.37e-05	0.000233	CcSEcCtD
Losartan—Paraesthesia—Capecitabine—prostate cancer	2.36e-05	0.000232	CcSEcCtD
Losartan—Decreased appetite—Docetaxel—prostate cancer	2.36e-05	0.000232	CcSEcCtD
Losartan—Asthenia—Etoposide—prostate cancer	2.35e-05	0.00023	CcSEcCtD
Losartan—Dyspnoea—Capecitabine—prostate cancer	2.35e-05	0.00023	CcSEcCtD
Losartan—Anaphylactic shock—Prednisone—prostate cancer	2.34e-05	0.00023	CcSEcCtD
Losartan—Oedema—Prednisone—prostate cancer	2.34e-05	0.00023	CcSEcCtD
Losartan—Fatigue—Docetaxel—prostate cancer	2.34e-05	0.00023	CcSEcCtD
Losartan—Angiopathy—Epirubicin—prostate cancer	2.34e-05	0.00023	CcSEcCtD
Losartan—Nausea—Mitoxantrone—prostate cancer	2.34e-05	0.000229	CcSEcCtD
Losartan—Infection—Prednisone—prostate cancer	2.33e-05	0.000228	CcSEcCtD
Losartan—Pain—Docetaxel—prostate cancer	2.32e-05	0.000228	CcSEcCtD
Losartan—Constipation—Docetaxel—prostate cancer	2.32e-05	0.000228	CcSEcCtD
Losartan—Dyspepsia—Capecitabine—prostate cancer	2.32e-05	0.000227	CcSEcCtD
Losartan—Pruritus—Etoposide—prostate cancer	2.31e-05	0.000227	CcSEcCtD
Losartan—Shock—Prednisone—prostate cancer	2.31e-05	0.000226	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—prostate cancer	2.3e-05	0.000226	CcSEcCtD
Losartan—Nervous system disorder—Prednisone—prostate cancer	2.3e-05	0.000226	CcSEcCtD
Losartan—Tachycardia—Prednisone—prostate cancer	2.29e-05	0.000224	CcSEcCtD
Losartan—Decreased appetite—Capecitabine—prostate cancer	2.29e-05	0.000224	CcSEcCtD
Losartan—Alopecia—Epirubicin—prostate cancer	2.28e-05	0.000224	CcSEcCtD
Losartan—Fatigue—Capecitabine—prostate cancer	2.27e-05	0.000223	CcSEcCtD
Losartan—Hyperhidrosis—Prednisone—prostate cancer	2.27e-05	0.000222	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—prostate cancer	2.26e-05	0.000222	CcSEcCtD
Losartan—Pain—Capecitabine—prostate cancer	2.25e-05	0.000221	CcSEcCtD
Losartan—Constipation—Capecitabine—prostate cancer	2.25e-05	0.000221	CcSEcCtD
Losartan—Erythema—Epirubicin—prostate cancer	2.25e-05	0.00022	CcSEcCtD
Losartan—Feeling abnormal—Docetaxel—prostate cancer	2.24e-05	0.00022	CcSEcCtD
Losartan—Diarrhoea—Etoposide—prostate cancer	2.24e-05	0.00022	CcSEcCtD
Losartan—Anorexia—Prednisone—prostate cancer	2.23e-05	0.000219	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—prostate cancer	2.23e-05	0.000218	CcSEcCtD
Losartan—Gastrointestinal pain—Docetaxel—prostate cancer	2.22e-05	0.000218	CcSEcCtD
Losartan—Flushing—Doxorubicin—prostate cancer	2.22e-05	0.000217	CcSEcCtD
Losartan—Flatulence—Epirubicin—prostate cancer	2.21e-05	0.000217	CcSEcCtD
Losartan—Tension—Epirubicin—prostate cancer	2.2e-05	0.000216	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—prostate cancer	2.2e-05	0.000216	CcSEcCtD
Losartan—Nervousness—Epirubicin—prostate cancer	2.18e-05	0.000214	CcSEcCtD
Losartan—Back pain—Epirubicin—prostate cancer	2.17e-05	0.000213	CcSEcCtD
Losartan—Feeling abnormal—Capecitabine—prostate cancer	2.17e-05	0.000213	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—prostate cancer	2.17e-05	0.000213	CcSEcCtD
Losartan—Dizziness—Etoposide—prostate cancer	2.16e-05	0.000212	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—prostate cancer	2.16e-05	0.000212	CcSEcCtD
Losartan—Gastrointestinal pain—Capecitabine—prostate cancer	2.15e-05	0.000211	CcSEcCtD
Losartan—Body temperature increased—Docetaxel—prostate cancer	2.15e-05	0.000211	CcSEcCtD
Losartan—Abdominal pain—Docetaxel—prostate cancer	2.15e-05	0.000211	CcSEcCtD
Losartan—Musculoskeletal discomfort—Prednisone—prostate cancer	2.14e-05	0.00021	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—prostate cancer	2.13e-05	0.000209	CcSEcCtD
Losartan—Insomnia—Prednisone—prostate cancer	2.12e-05	0.000208	CcSEcCtD
Losartan—Vision blurred—Epirubicin—prostate cancer	2.12e-05	0.000208	CcSEcCtD
Losartan—Alopecia—Doxorubicin—prostate cancer	2.11e-05	0.000207	CcSEcCtD
Losartan—Paraesthesia—Prednisone—prostate cancer	2.1e-05	0.000207	CcSEcCtD
Losartan—Urticaria—Capecitabine—prostate cancer	2.09e-05	0.000205	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—prostate cancer	2.08e-05	0.000204	CcSEcCtD
Losartan—Abdominal pain—Capecitabine—prostate cancer	2.08e-05	0.000204	CcSEcCtD
Losartan—Body temperature increased—Capecitabine—prostate cancer	2.08e-05	0.000204	CcSEcCtD
Losartan—Vomiting—Etoposide—prostate cancer	2.08e-05	0.000204	CcSEcCtD
Losartan—Erythema—Doxorubicin—prostate cancer	2.08e-05	0.000204	CcSEcCtD
Losartan—Anaemia—Epirubicin—prostate cancer	2.08e-05	0.000204	CcSEcCtD
Losartan—Agitation—Epirubicin—prostate cancer	2.06e-05	0.000203	CcSEcCtD
Losartan—Dyspepsia—Prednisone—prostate cancer	2.06e-05	0.000202	CcSEcCtD
Losartan—Rash—Etoposide—prostate cancer	2.06e-05	0.000202	CcSEcCtD
Losartan—Dermatitis—Etoposide—prostate cancer	2.06e-05	0.000202	CcSEcCtD
Losartan—Headache—Etoposide—prostate cancer	2.05e-05	0.000201	CcSEcCtD
Losartan—Flatulence—Doxorubicin—prostate cancer	2.05e-05	0.000201	CcSEcCtD
Losartan—Tension—Doxorubicin—prostate cancer	2.04e-05	0.0002	CcSEcCtD
Losartan—Decreased appetite—Prednisone—prostate cancer	2.04e-05	0.0002	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—prostate cancer	2.04e-05	0.0002	CcSEcCtD
Losartan—Malaise—Epirubicin—prostate cancer	2.03e-05	0.000199	CcSEcCtD
Losartan—Fatigue—Prednisone—prostate cancer	2.02e-05	0.000198	CcSEcCtD
Losartan—Nervousness—Doxorubicin—prostate cancer	2.02e-05	0.000198	CcSEcCtD
Losartan—Vertigo—Epirubicin—prostate cancer	2.02e-05	0.000198	CcSEcCtD
Losartan—Syncope—Epirubicin—prostate cancer	2.01e-05	0.000198	CcSEcCtD
Losartan—Leukopenia—Epirubicin—prostate cancer	2.01e-05	0.000197	CcSEcCtD
Losartan—Back pain—Doxorubicin—prostate cancer	2.01e-05	0.000197	CcSEcCtD
Losartan—Constipation—Prednisone—prostate cancer	2e-05	0.000197	CcSEcCtD
Losartan—Hypersensitivity—Docetaxel—prostate cancer	2e-05	0.000196	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—prostate cancer	2e-05	0.000196	CcSEcCtD
Losartan—Palpitations—Epirubicin—prostate cancer	1.98e-05	0.000195	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—prostate cancer	1.97e-05	0.000194	CcSEcCtD
Losartan—Cough—Epirubicin—prostate cancer	1.96e-05	0.000192	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—prostate cancer	1.96e-05	0.000192	CcSEcCtD
Losartan—Asthenia—Docetaxel—prostate cancer	1.95e-05	0.000191	CcSEcCtD
Losartan—Nausea—Etoposide—prostate cancer	1.94e-05	0.000191	CcSEcCtD
Losartan—Hypersensitivity—Capecitabine—prostate cancer	1.94e-05	0.00019	CcSEcCtD
Losartan—Feeling abnormal—Prednisone—prostate cancer	1.93e-05	0.00019	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—prostate cancer	1.93e-05	0.000189	CcSEcCtD
Losartan—Pruritus—Docetaxel—prostate cancer	1.92e-05	0.000189	CcSEcCtD
Losartan—Anaemia—Doxorubicin—prostate cancer	1.92e-05	0.000188	CcSEcCtD
Losartan—Gastrointestinal pain—Prednisone—prostate cancer	1.92e-05	0.000188	CcSEcCtD
Losartan—Chest pain—Epirubicin—prostate cancer	1.91e-05	0.000188	CcSEcCtD
Losartan—Myalgia—Epirubicin—prostate cancer	1.91e-05	0.000188	CcSEcCtD
Losartan—Arthralgia—Epirubicin—prostate cancer	1.91e-05	0.000188	CcSEcCtD
Losartan—Agitation—Doxorubicin—prostate cancer	1.91e-05	0.000187	CcSEcCtD
Losartan—Anxiety—Epirubicin—prostate cancer	1.91e-05	0.000187	CcSEcCtD
Losartan—Discomfort—Epirubicin—prostate cancer	1.89e-05	0.000185	CcSEcCtD
Losartan—Asthenia—Capecitabine—prostate cancer	1.89e-05	0.000185	CcSEcCtD
Losartan—Malaise—Doxorubicin—prostate cancer	1.87e-05	0.000184	CcSEcCtD
Losartan—Dry mouth—Epirubicin—prostate cancer	1.87e-05	0.000184	CcSEcCtD
Losartan—Vertigo—Doxorubicin—prostate cancer	1.87e-05	0.000183	CcSEcCtD
Losartan—Syncope—Doxorubicin—prostate cancer	1.86e-05	0.000183	CcSEcCtD
Losartan—Urticaria—Prednisone—prostate cancer	1.86e-05	0.000183	CcSEcCtD
Losartan—Pruritus—Capecitabine—prostate cancer	1.86e-05	0.000183	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—prostate cancer	1.86e-05	0.000183	CcSEcCtD
Losartan—Diarrhoea—Docetaxel—prostate cancer	1.86e-05	0.000182	CcSEcCtD
Losartan—Body temperature increased—Prednisone—prostate cancer	1.85e-05	0.000182	CcSEcCtD
Losartan—Abdominal pain—Prednisone—prostate cancer	1.85e-05	0.000182	CcSEcCtD
Losartan—Confusional state—Epirubicin—prostate cancer	1.85e-05	0.000181	CcSEcCtD
Losartan—Palpitations—Doxorubicin—prostate cancer	1.84e-05	0.00018	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—prostate cancer	1.83e-05	0.00018	CcSEcCtD
Losartan—Oedema—Epirubicin—prostate cancer	1.83e-05	0.00018	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—prostate cancer	1.83e-05	0.000179	CcSEcCtD
Losartan—Infection—Epirubicin—prostate cancer	1.82e-05	0.000179	CcSEcCtD
Losartan—Cough—Doxorubicin—prostate cancer	1.81e-05	0.000178	CcSEcCtD
Losartan—Shock—Epirubicin—prostate cancer	1.8e-05	0.000177	CcSEcCtD
Losartan—Diarrhoea—Capecitabine—prostate cancer	1.8e-05	0.000177	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—prostate cancer	1.8e-05	0.000176	CcSEcCtD
Losartan—Dizziness—Docetaxel—prostate cancer	1.8e-05	0.000176	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—prostate cancer	1.79e-05	0.000176	CcSEcCtD
Losartan—Tachycardia—Epirubicin—prostate cancer	1.79e-05	0.000176	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—prostate cancer	1.77e-05	0.000174	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—prostate cancer	1.77e-05	0.000174	CcSEcCtD
Losartan—Chest pain—Doxorubicin—prostate cancer	1.77e-05	0.000174	CcSEcCtD
Losartan—Myalgia—Doxorubicin—prostate cancer	1.77e-05	0.000174	CcSEcCtD
Losartan—Anxiety—Doxorubicin—prostate cancer	1.76e-05	0.000173	CcSEcCtD
Losartan—Discomfort—Doxorubicin—prostate cancer	1.75e-05	0.000172	CcSEcCtD
Losartan—Anorexia—Epirubicin—prostate cancer	1.75e-05	0.000171	CcSEcCtD
Losartan—Dizziness—Capecitabine—prostate cancer	1.74e-05	0.000171	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—prostate cancer	1.73e-05	0.00017	CcSEcCtD
Losartan—Vomiting—Docetaxel—prostate cancer	1.73e-05	0.00017	CcSEcCtD
Losartan—Hypersensitivity—Prednisone—prostate cancer	1.73e-05	0.000169	CcSEcCtD
Losartan—Rash—Docetaxel—prostate cancer	1.71e-05	0.000168	CcSEcCtD
Losartan—Hypotension—Epirubicin—prostate cancer	1.71e-05	0.000168	CcSEcCtD
Losartan—Dermatitis—Docetaxel—prostate cancer	1.71e-05	0.000168	CcSEcCtD
Losartan—Confusional state—Doxorubicin—prostate cancer	1.71e-05	0.000168	CcSEcCtD
Losartan—Headache—Docetaxel—prostate cancer	1.7e-05	0.000167	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—prostate cancer	1.7e-05	0.000166	CcSEcCtD
Losartan—Oedema—Doxorubicin—prostate cancer	1.7e-05	0.000166	CcSEcCtD
Losartan—Infection—Doxorubicin—prostate cancer	1.68e-05	0.000165	CcSEcCtD
Losartan—Asthenia—Prednisone—prostate cancer	1.68e-05	0.000165	CcSEcCtD
Losartan—Vomiting—Capecitabine—prostate cancer	1.67e-05	0.000164	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.67e-05	0.000164	CcSEcCtD
Losartan—Shock—Doxorubicin—prostate cancer	1.67e-05	0.000164	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—prostate cancer	1.66e-05	0.000163	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—prostate cancer	1.66e-05	0.000163	CcSEcCtD
Losartan—Rash—Capecitabine—prostate cancer	1.66e-05	0.000163	CcSEcCtD
Losartan—Pruritus—Prednisone—prostate cancer	1.66e-05	0.000163	CcSEcCtD
Losartan—Insomnia—Epirubicin—prostate cancer	1.66e-05	0.000163	CcSEcCtD
Losartan—Dermatitis—Capecitabine—prostate cancer	1.66e-05	0.000163	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—prostate cancer	1.66e-05	0.000162	CcSEcCtD
Losartan—Headache—Capecitabine—prostate cancer	1.65e-05	0.000162	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—prostate cancer	1.65e-05	0.000162	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—prostate cancer	1.64e-05	0.000161	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—prostate cancer	1.63e-05	0.00016	CcSEcCtD
Losartan—Somnolence—Epirubicin—prostate cancer	1.63e-05	0.00016	CcSEcCtD
Losartan—Anorexia—Doxorubicin—prostate cancer	1.62e-05	0.000159	CcSEcCtD
Losartan—Nausea—Docetaxel—prostate cancer	1.61e-05	0.000158	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—prostate cancer	1.61e-05	0.000158	CcSEcCtD
Losartan—Diarrhoea—Prednisone—prostate cancer	1.6e-05	0.000157	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—prostate cancer	1.59e-05	0.000156	CcSEcCtD
Losartan—Hypotension—Doxorubicin—prostate cancer	1.58e-05	0.000156	CcSEcCtD
Losartan—Fatigue—Epirubicin—prostate cancer	1.58e-05	0.000155	CcSEcCtD
Losartan—Pain—Epirubicin—prostate cancer	1.57e-05	0.000154	CcSEcCtD
Losartan—Constipation—Epirubicin—prostate cancer	1.57e-05	0.000154	CcSEcCtD
Losartan—Nausea—Capecitabine—prostate cancer	1.56e-05	0.000153	CcSEcCtD
Losartan—Dizziness—Prednisone—prostate cancer	1.55e-05	0.000152	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.55e-05	0.000152	CcSEcCtD
Losartan—Insomnia—Doxorubicin—prostate cancer	1.53e-05	0.000151	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—prostate cancer	1.52e-05	0.000149	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—prostate cancer	1.51e-05	0.000148	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—prostate cancer	1.51e-05	0.000148	CcSEcCtD
Losartan—Somnolence—Doxorubicin—prostate cancer	1.51e-05	0.000148	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—prostate cancer	1.5e-05	0.000147	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—prostate cancer	1.49e-05	0.000147	CcSEcCtD
Losartan—Vomiting—Prednisone—prostate cancer	1.49e-05	0.000146	CcSEcCtD
Losartan—Rash—Prednisone—prostate cancer	1.48e-05	0.000145	CcSEcCtD
Losartan—Dermatitis—Prednisone—prostate cancer	1.48e-05	0.000145	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—prostate cancer	1.47e-05	0.000145	CcSEcCtD
Losartan—Headache—Prednisone—prostate cancer	1.47e-05	0.000144	CcSEcCtD
Losartan—Fatigue—Doxorubicin—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Losartan—Urticaria—Epirubicin—prostate cancer	1.46e-05	0.000143	CcSEcCtD
Losartan—Pain—Doxorubicin—prostate cancer	1.45e-05	0.000142	CcSEcCtD
Losartan—Constipation—Doxorubicin—prostate cancer	1.45e-05	0.000142	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—prostate cancer	1.45e-05	0.000142	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—prostate cancer	1.45e-05	0.000142	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—prostate cancer	1.4e-05	0.000137	CcSEcCtD
Losartan—Nausea—Prednisone—prostate cancer	1.39e-05	0.000137	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—prostate cancer	1.39e-05	0.000136	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—prostate cancer	1.35e-05	0.000133	CcSEcCtD
Losartan—Urticaria—Doxorubicin—prostate cancer	1.35e-05	0.000132	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—prostate cancer	1.34e-05	0.000132	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—prostate cancer	1.34e-05	0.000132	CcSEcCtD
Losartan—Asthenia—Epirubicin—prostate cancer	1.32e-05	0.000129	CcSEcCtD
Losartan—Pruritus—Epirubicin—prostate cancer	1.3e-05	0.000127	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—prostate cancer	1.25e-05	0.000123	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—prostate cancer	1.25e-05	0.000123	CcSEcCtD
Losartan—Asthenia—Doxorubicin—prostate cancer	1.22e-05	0.000119	CcSEcCtD
Losartan—Dizziness—Epirubicin—prostate cancer	1.21e-05	0.000119	CcSEcCtD
Losartan—Pruritus—Doxorubicin—prostate cancer	1.2e-05	0.000118	CcSEcCtD
Losartan—Vomiting—Epirubicin—prostate cancer	1.17e-05	0.000114	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—prostate cancer	1.16e-05	0.000114	CcSEcCtD
Losartan—Rash—Epirubicin—prostate cancer	1.16e-05	0.000113	CcSEcCtD
Losartan—Dermatitis—Epirubicin—prostate cancer	1.15e-05	0.000113	CcSEcCtD
Losartan—Headache—Epirubicin—prostate cancer	1.15e-05	0.000113	CcSEcCtD
Losartan—Dizziness—Doxorubicin—prostate cancer	1.12e-05	0.00011	CcSEcCtD
Losartan—Nausea—Epirubicin—prostate cancer	1.09e-05	0.000107	CcSEcCtD
Losartan—Vomiting—Doxorubicin—prostate cancer	1.08e-05	0.000106	CcSEcCtD
Losartan—Rash—Doxorubicin—prostate cancer	1.07e-05	0.000105	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—prostate cancer	1.07e-05	0.000105	CcSEcCtD
Losartan—Headache—Doxorubicin—prostate cancer	1.06e-05	0.000104	CcSEcCtD
Losartan—Nausea—Doxorubicin—prostate cancer	1.01e-05	9.89e-05	CcSEcCtD
Losartan—CYP1A2—Metabolism—CYP17A1—prostate cancer	9.14e-07	9.91e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	9.11e-07	9.88e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP19A1—prostate cancer	9.06e-07	9.83e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—P4HB—prostate cancer	9.04e-07	9.8e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTHFR—prostate cancer	9.03e-07	9.79e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.02e-07	9.78e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1B1—prostate cancer	9.01e-07	9.77e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—prostate cancer	8.97e-07	9.73e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—RXRA—prostate cancer	8.96e-07	9.72e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—prostate cancer	8.95e-07	9.7e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TYMS—prostate cancer	8.95e-07	9.7e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—TYMS—prostate cancer	8.9e-07	9.65e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARA—prostate cancer	8.85e-07	9.6e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTM1—prostate cancer	8.85e-07	9.59e-06	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—prostate cancer	8.84e-07	9.59e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTM1—prostate cancer	8.8e-07	9.54e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC22A1—prostate cancer	8.79e-07	9.53e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—prostate cancer	8.77e-07	9.51e-06	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CB—prostate cancer	8.76e-07	9.5e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—RXRA—prostate cancer	8.75e-07	9.49e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GGT1—prostate cancer	8.72e-07	9.46e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	8.72e-07	9.45e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NCOA2—prostate cancer	8.71e-07	9.45e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—LPL—prostate cancer	8.68e-07	9.42e-06	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—prostate cancer	8.68e-07	9.41e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—LPL—prostate cancer	8.63e-07	9.36e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—COMT—prostate cancer	8.63e-07	9.36e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTP1—prostate cancer	8.59e-07	9.32e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NCOA1—prostate cancer	8.59e-07	9.32e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.57e-07	9.29e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP19A1—prostate cancer	8.47e-07	9.18e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ITPR1—prostate cancer	8.45e-07	9.17e-06	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—prostate cancer	8.43e-07	9.14e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MED12—prostate cancer	8.43e-07	9.14e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—COMT—prostate cancer	8.43e-07	9.14e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTP1—prostate cancer	8.39e-07	9.09e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1A1—prostate cancer	8.39e-07	9.09e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNG5—prostate cancer	8.36e-07	9.07e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1A1—prostate cancer	8.34e-07	9.04e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CAV1—prostate cancer	8.33e-07	9.03e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ERCC2—prostate cancer	8.32e-07	9.02e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.31e-07	9.01e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC5A5—prostate cancer	8.31e-07	9.01e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—prostate cancer	8.29e-07	8.99e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—ERCC2—prostate cancer	8.27e-07	8.97e-06	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—prostate cancer	8.26e-07	8.96e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ITPR1—prostate cancer	8.25e-07	8.95e-06	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—prostate cancer	8.19e-07	8.88e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—RXRA—prostate cancer	8.17e-07	8.86e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP2E1—prostate cancer	8.12e-07	8.8e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOA3—prostate cancer	8.06e-07	8.74e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NQO1—prostate cancer	8.03e-07	8.7e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TYMS—prostate cancer	7.99e-07	8.66e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.95e-07	8.62e-06	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—prostate cancer	7.95e-07	8.62e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TH—prostate cancer	7.91e-07	8.58e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTM1—prostate cancer	7.9e-07	8.56e-06	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—EP300—prostate cancer	7.88e-07	8.54e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—COMT—prostate cancer	7.87e-07	8.54e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.86e-07	8.52e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTP1—prostate cancer	7.83e-07	8.5e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP3A4—prostate cancer	7.83e-07	8.49e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTHFR—prostate cancer	7.82e-07	8.48e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TYMS—prostate cancer	7.8e-07	8.45e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.79e-07	8.44e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—MTHFR—prostate cancer	7.77e-07	8.43e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—LPL—prostate cancer	7.75e-07	8.4e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ITPR1—prostate cancer	7.71e-07	8.36e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTM1—prostate cancer	7.71e-07	8.36e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1B1—prostate cancer	7.7e-07	8.34e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HPGDS—prostate cancer	7.68e-07	8.33e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARA—prostate cancer	7.67e-07	8.32e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.64e-07	8.28e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARA—prostate cancer	7.63e-07	8.27e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—prostate cancer	7.62e-07	8.26e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—prostate cancer	7.58e-07	8.22e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	7.58e-07	8.22e-06	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—prostate cancer	7.57e-07	8.21e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—LPL—prostate cancer	7.56e-07	8.2e-06	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—prostate cancer	7.52e-07	8.16e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1A1—prostate cancer	7.48e-07	8.12e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ACHE—prostate cancer	7.45e-07	8.08e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTT1—prostate cancer	7.45e-07	8.08e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GGT1—prostate cancer	7.45e-07	8.08e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ERCC2—prostate cancer	7.42e-07	8.05e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2A6—prostate cancer	7.37e-07	7.99e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—prostate cancer	7.37e-07	7.99e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NCOA1—prostate cancer	7.34e-07	7.96e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1A1—prostate cancer	7.31e-07	7.92e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TYMS—prostate cancer	7.28e-07	7.9e-06	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—prostate cancer	7.28e-07	7.89e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ERCC2—prostate cancer	7.25e-07	7.86e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP19A1—prostate cancer	7.24e-07	7.85e-06	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—EP300—prostate cancer	7.22e-07	7.83e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CAV1—prostate cancer	7.21e-07	7.82e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTM1—prostate cancer	7.2e-07	7.81e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—INS—prostate cancer	7.18e-07	7.78e-06	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—prostate cancer	7.17e-07	7.78e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—CAV1—prostate cancer	7.17e-07	7.77e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C3—prostate cancer	7.17e-07	7.77e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PRKACB—prostate cancer	7.13e-07	7.73e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LPL—prostate cancer	7.07e-07	7.66e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP17A1—prostate cancer	7.06e-07	7.65e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CREBBP—prostate cancer	7.03e-07	7.62e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RXRA—prostate cancer	6.98e-07	7.57e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTHFR—prostate cancer	6.98e-07	7.57e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.89e-07	7.47e-06	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—prostate cancer	6.89e-07	7.47e-06	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.85e-07	7.43e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARA—prostate cancer	6.85e-07	7.42e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1A1—prostate cancer	6.82e-07	7.4e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTHFR—prostate cancer	6.81e-07	7.39e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.79e-07	7.36e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ERCC2—prostate cancer	6.77e-07	7.34e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—prostate cancer	6.74e-07	7.31e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—COMT—prostate cancer	6.73e-07	7.29e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOA2—prostate cancer	6.72e-07	7.29e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTP1—prostate cancer	6.69e-07	7.26e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARA—prostate cancer	6.68e-07	7.25e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CD—prostate cancer	6.67e-07	7.23e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ITPR1—prostate cancer	6.59e-07	7.14e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—prostate cancer	6.57e-07	7.12e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—prostate cancer	6.53e-07	7.08e-06	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—prostate cancer	6.49e-07	7.04e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.48e-07	7.02e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CAV1—prostate cancer	6.44e-07	6.98e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.41e-07	6.96e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTHFR—prostate cancer	6.36e-07	6.9e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NOS3—prostate cancer	6.29e-07	6.83e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CAV1—prostate cancer	6.28e-07	6.81e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP2E1—prostate cancer	6.26e-07	6.79e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARA—prostate cancer	6.24e-07	6.77e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TYMS—prostate cancer	6.22e-07	6.75e-06	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—prostate cancer	6.22e-07	6.75e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—INS—prostate cancer	6.22e-07	6.74e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NQO1—prostate cancer	6.19e-07	6.72e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—INS—prostate cancer	6.18e-07	6.7e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTM1—prostate cancer	6.15e-07	6.67e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.15e-07	6.67e-06	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—prostate cancer	6.15e-07	6.67e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TH—prostate cancer	6.11e-07	6.62e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CREBBP—prostate cancer	6.09e-07	6.6e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—CREBBP—prostate cancer	6.05e-07	6.57e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LPL—prostate cancer	6.04e-07	6.55e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.94e-07	6.44e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CAV1—prostate cancer	5.87e-07	6.36e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—prostate cancer	5.86e-07	6.36e-06	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—prostate cancer	5.86e-07	6.35e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1A1—prostate cancer	5.83e-07	6.32e-06	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—prostate cancer	5.83e-07	6.32e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CB—prostate cancer	5.81e-07	6.3e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ERCC2—prostate cancer	5.78e-07	6.27e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CD—prostate cancer	5.77e-07	6.26e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—prostate cancer	5.76e-07	6.24e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GGT1—prostate cancer	5.75e-07	6.24e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CD—prostate cancer	5.74e-07	6.23e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—prostate cancer	5.72e-07	6.21e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOA1—prostate cancer	5.67e-07	6.14e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.61e-07	6.08e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.58e-07	6.06e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—INS—prostate cancer	5.55e-07	6.02e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NOS3—prostate cancer	5.45e-07	5.91e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTHFR—prostate cancer	5.44e-07	5.9e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CREBBP—prostate cancer	5.44e-07	5.89e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—NOS3—prostate cancer	5.42e-07	5.88e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—INS—prostate cancer	5.42e-07	5.87e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RXRA—prostate cancer	5.39e-07	5.84e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—prostate cancer	5.35e-07	5.8e-06	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—prostate cancer	5.34e-07	5.79e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARA—prostate cancer	5.33e-07	5.78e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CREBBP—prostate cancer	5.31e-07	5.75e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—COMT—prostate cancer	5.19e-07	5.63e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTP1—prostate cancer	5.17e-07	5.6e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CD—prostate cancer	5.15e-07	5.59e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ITPR1—prostate cancer	5.08e-07	5.51e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—INS—prostate cancer	5.06e-07	5.49e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CB—prostate cancer	5.03e-07	5.46e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CD—prostate cancer	5.03e-07	5.45e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—prostate cancer	5.02e-07	5.44e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CAV1—prostate cancer	5.01e-07	5.44e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CB—prostate cancer	5e-07	5.43e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—prostate cancer	4.99e-07	5.41e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—prostate cancer	4.96e-07	5.38e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CREBBP—prostate cancer	4.96e-07	5.37e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NOS3—prostate cancer	4.87e-07	5.28e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMS—prostate cancer	4.8e-07	5.21e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.79e-07	5.2e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—EP300—prostate cancer	4.79e-07	5.19e-06	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—prostate cancer	4.76e-07	5.16e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NOS3—prostate cancer	4.75e-07	5.15e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTM1—prostate cancer	4.75e-07	5.15e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CD—prostate cancer	4.7e-07	5.1e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LPL—prostate cancer	4.66e-07	5.05e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—prostate cancer	4.57e-07	4.95e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.5e-07	4.88e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CB—prostate cancer	4.49e-07	4.87e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ERCC2—prostate cancer	4.46e-07	4.84e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—prostate cancer	4.45e-07	4.83e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NOS3—prostate cancer	4.44e-07	4.81e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CB—prostate cancer	4.38e-07	4.75e-06	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—prostate cancer	4.36e-07	4.73e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—prostate cancer	4.35e-07	4.72e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—prostate cancer	4.34e-07	4.71e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—prostate cancer	4.32e-07	4.69e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—INS—prostate cancer	4.32e-07	4.69e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CREBBP—prostate cancer	4.24e-07	4.59e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTHFR—prostate cancer	4.2e-07	4.55e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—EP300—prostate cancer	4.15e-07	4.5e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—EP300—prostate cancer	4.12e-07	4.47e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARA—prostate cancer	4.12e-07	4.46e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CB—prostate cancer	4.1e-07	4.44e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—prostate cancer	4.06e-07	4.4e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CD—prostate cancer	4.02e-07	4.35e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—prostate cancer	3.88e-07	4.21e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CAV1—prostate cancer	3.87e-07	4.2e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NOS3—prostate cancer	3.79e-07	4.11e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—prostate cancer	3.79e-07	4.11e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—EP300—prostate cancer	3.7e-07	4.01e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—EP300—prostate cancer	3.61e-07	3.92e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—prostate cancer	3.54e-07	3.84e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—prostate cancer	3.54e-07	3.84e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.53e-07	3.82e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.5e-07	3.8e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—prostate cancer	3.47e-07	3.76e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—EP300—prostate cancer	3.38e-07	3.66e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—INS—prostate cancer	3.34e-07	3.62e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CREBBP—prostate cancer	3.27e-07	3.54e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.1e-07	3.36e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.07e-07	3.33e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—prostate cancer	3.05e-07	3.31e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—prostate cancer	3.02e-07	3.28e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NOS3—prostate cancer	2.93e-07	3.17e-06	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—prostate cancer	2.89e-07	3.14e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—EP300—prostate cancer	2.88e-07	3.13e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.74e-07	2.97e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.7e-07	2.93e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—prostate cancer	2.68e-07	2.9e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—prostate cancer	2.67e-07	2.9e-06	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—prostate cancer	2.51e-07	2.72e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.5e-07	2.71e-06	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—prostate cancer	2.49e-07	2.7e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—prostate cancer	2.33e-07	2.53e-06	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—prostate cancer	2.24e-07	2.43e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—EP300—prostate cancer	2.23e-07	2.41e-06	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—prostate cancer	2.18e-07	2.37e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.13e-07	2.31e-06	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—prostate cancer	2.04e-07	2.21e-06	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—prostate cancer	1.74e-07	1.89e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.65e-07	1.79e-06	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—prostate cancer	1.35e-07	1.46e-06	CbGpPWpGaD
